Comparison 2. BDF versus Terbutaline as reliever (Children with BDF maintenance).

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Children with an exacerbation causing hospitalisation	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
2 Children with non‐fatal Serious Adverse Events	1		Odds Ratio (M‐H, Fixed, 95% CI)	Totals not selected
3 FEV1 (Change from baseline) Litres	1		Mean Difference (Fixed, 95% CI)	Totals not selected
4 Morning Peak Flow (Change from baseline) L/min	1		Mean Difference (Fixed, 95% CI)	Totals not selected
5 Evening Peak Flow (Change from baseline) L/min	1		Mean Difference (Fixed, 95% CI)	Totals not selected
6 Change in reliever use (puffs per 24 hours)	1		Mean Difference (Fixed, 95% CI)	Totals not selected
7 Change in % nights with awakenings	1		Mean Difference (Fixed, 95% CI)	Totals not selected
8 Change in % Asthma Control Days	1		Mean Difference (Fixed, 95% CI)	Totals not selected
9 Annual Height Gain (cms)	1		Mean Difference (IV, Fixed, 95% CI)	Totals not selected